Wockhardt Ltd shares surged 2.19% to trade at ₹2,067 as of 12:49 IST on the NSE, marking the third consecutive session of gains. According to reports from Business Standard, the pharmaceutical company's stock has demonstrated strong momentum with a 22.5% gain over the past year, significantly outperforming the benchmark NIFTY's 2.73% gain and the Nifty Pharma index's 12.64% gain during the same period.
The broader market showed mixed performance with the NIFTY trading at 24,117.4, up 0.13% for the day, while the Sensex stood at 77,296.67, gaining 0.18%. As reported by Business Standard, the Nifty Pharma index was quoted at 24,146.55, up 0.02% on the day, with the sector showing a 2.88% gain over the past month. Wockhardt has particularly benefited from this sectoral strength, adding 27.58% in the last one month alone.
Trading volume for Wockhardt shares stood at 19.11 lakh shares during the current session, which is lower than the 34.17 lakh shares average daily volume recorded over the past month. According to Business Standard, this reduced trading activity suggests the stock's recent gains may be driven more by fundamental factors rather than increased investor interest. The stock's PE ratio of 112.56 is based on trailing twelve months earnings ending March 2026.
Wockhardt has received a credit rating upgrade from ICRA with the company moving from BBB; Positive / ICRA A3+ to ICRA A-; Stable / ICRA A2+. The company has also scheduled a Board of Directors meeting on 4 May 2026. Additionally, the stock has shown strong performance with gains of 22.73% in the last one month, significantly outperforming the Nifty Pharma index's 6.68% gain during the same period.
